IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency
Status:
Unknown status
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
Immunoglobulin G deficiency subtypes in patients with asthma six months once a month
intravenous immunoglobulin (400mg/kg/4weeks) infection in treatment-related effect on
reducing the frequency of asthma exacerbations appreciate.
Phase:
Phase 3
Details
Lead Sponsor:
Ajou University School of Medicine
Treatments:
Antibodies gamma-Globulins Immunoglobulin G Immunoglobulins Immunoglobulins, Intravenous Rho(D) Immune Globulin